Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals
Patent
1995-06-07
1998-03-31
Wolski, Susan
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
435 78, 435 792, 435 793, 435 794, 436501, 436540, 436548, 436811, 436817, 5303871, 5303881, 53038824, 5303891, 5303892, 5303911, 5303913, G01N 33543
Patent
active
057337900
ABSTRACT:
Corticotropin Releasing Factor-binding protein (CRF-BP) is produced recombinantly and is useful for modulating the biological activity of CRF. CRF-BP or fragments thereof and/or antibodies to such polypeptides are employed in diagnostic assays to determine the levels of CRF and CRF-BP and the ratio of CRF/CRF-BP in a vascular fluid sample. Following such an assay, pregnancy-related pathological disorders, such as increased risk of premature labor, can be treated, for example, by administering CRF-BP to lower the ratio of CRF/CRF-BP to within a normal range for pregnancy. Anti-CRF-BP antibodies are also useful to purify CRF-BP and to modulate the biological effect of CRF-BPs.
REFERENCES:
Linton et al., "Carticotripin-Releasing Hormone (CRH)-Binding Protein: Reduction in the Adrenocorticotripin-Releasing Activity of Placental but no Hypothalamic CRH," Journal of Clinical Endocrinology and Metabolism, vol. 70, No. 6, pp. 1574-1580, (1990).
Linton et al., "Purified CRF Binding Protein Reduces at ACTH-Releasing Activity of CRF," Journal of Endocrinology, vol. 121, supplement, abstract 194, (Apr. 1989).
Potter et al., "The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF", Proceedings of the National Academy of Sciences, vol. 89, pp. 4192-4196, (1992).
Linton et al., "Comparison of a specific two-site immunoradiometric assay with radioimmunoassay for rat/human CRF-41," Regulatory Peptides, vol. 14, No. 1, pp. 69-84, (1986).
Linton et al., "Corticotropin Releasing Hormone-Binding Protein (CRH-BP): Plasma Levels Decrease During the Third Trimester of Normal Human Pregnancy," Journal of Clinical Endocrinology and Metabolism, vol. 76, No. 1, pp. 260-262, (1993).
Behan Dominic P.
Linton Elizabeth A.
Lowry Philip J.
Potter Ellen
Vale, Jr. Wylie W.
The Salk Institute for Biological Studies
The University of Reading
Wolski Susan
LandOfFree
CRF binding protein antibodies and assays using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CRF binding protein antibodies and assays using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CRF binding protein antibodies and assays using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-51263